 |
Somatropin (rDNA origin) injection |
|---|---|
| Trade Name | Norditropin |
| Orphan Indication | Growth failure in children due to inadequate growth hormone secretion |
| USA Market Approval | USA |
| USA Designation Date | 1987-07-10 00:00:00 |
| Sponsor | Novo Nordisk Pharmaceuticals;100 Overlook Center, Suite 200;Princeton, NJ, 08540 |
